Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - linezolidum - soluzione per infusione - linezolidum 2 mg, glucosum monohydricum 48 mg, acidum citricum, natrii citras dihydricus, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabilia q.s. ad solutionem pro 1 ml corresp. natrium 0.38 mg. - malattie infettive - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - linezolidum - lnfusionslösung - linezolidum 2 mg, natrii citras dihydricus corresp. natrium 0.38 mg, acidum citricum, glucosum monohydricum corresp. glucosum 45.7 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - malattie infettive - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - linezolidum - compresse rivestite con film - linezolidum 600 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum, carboxymethylamylum natricum a corresp. natrium max. 3.4 mg, magnesii stearas, Überzug: cera carnauba, hypromellosum, e 171, macrogolum 400, pro compresso obducto. - malattie infettive - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - linezolidum - granulato per sospensione orale - linezolidum 20 mg, saccharum 210.58 mg, acidum citricum, natrii citras anhydricus, cellulosum microcristallinum, carmellosum natricum, aspartamum 7 mg, xanthani gummi, mannitolum, e 211 2 mg, aromatica (orange) cum ethanolum 0.2 mg et maltodextrinum, silica colloidalis anhydrica, aromatica (pfefferminze), aromatica (vanille) cum propylenglycolum et alcohol benzylicus et maltodextrinum, natrii chloridum, sorbitolum 8.76 mg, fructosum 3.36 mg, maltodextrinum, acidum glycyrrhizinicum, ammonii glycyrrhizas, triglycerida media, aromatica (orangencrème) cum ethanolum et amylum modificatum et maltodextrinum, ad granulatum corresp. suspensio reconstituta 1 ml corresp. natrium 2.279 mg. - malattie infettive - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - linezolidum - compresse rivestite con film - linezolidum 600 mg, cellulosum microcristallinum, silica colloidalis anhydrica, carboxymethylamylum natricum a corresp. natrium max. 2.1 mg, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, pro compresso obducto. - malattie infettive - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - linezolidum - granulato per sospensione orale - linezolidum 20 mg, saccharum 210.58 mg, acidum citricum, natrii citras anhydricus, cellulosum microcristallinum, carmellosum natricum, aspartamum 7 mg, xanthani gummi, mannitolum, e 211 2 mg, aromatica (orange) cum ethanolum 0.2 mg et maltodextrinum, silica colloidalis anhydrica, aromatica (pfefferminze), aromatica (vanille) cum propylenglycolum et alcohol benzylicus et maltodextrinum, natrii chloridum, sorbitolum 8.76 mg, fructosum 3.36 mg, maltodextrinum, acidum glycyrrhizinicum, ammonii glycyrrhizas, triglycerida media, aromatica (orangencrème) cum ethanolum et amylum modificatum et maltodextrinum, ad granulatum corresp. suspensio reconstituta 1 ml corresp. natrium 2.279 mg. - malattie infettive - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - linezolidum - compresse rivestite con film - linezolidum 600 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum, carboxymethylamylum natricum a corresp. natrium max. 3.4 mg, magnesii stearas, Überzug: cera carnauba, hypromellosum, e 171, macrogolum 400, pro compresso obducto. - malattie infettive - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - atomoxetinum - capsule rigide - atomoxetinum 10 mg corresp. atomoxetini hydrochloridum 11.43 mg, maydis amylum, amylum pregelificatum, dimeticonum 350, carboxymethylamylum natricum a, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.25 mg. - centrale efficace ad azione prolungata, non stimolante - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - atomoxetinum - capsule rigide - atomoxetinum 18 mg corresp. atomoxetini hydrochloridum 20.57 mg, maydis amylum, amylum pregelificatum, dimeticonum 350, carboxymethylamylum natricum a, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.45 mg. - centrale efficace ad azione prolungata, non stimolante - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - atomoxetinum - capsule rigide - atomoxetinum 25 mg corresp. atomoxetini hydrochloridum 28.58 mg, maydis amylum, amylum pregelificatum, dimeticonum 350, carboxymethylamylum natricum a, kapselhülle: gelatina, e 132, e 171, e 172 (nigrum), drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.63 mg. - centrale efficace ad azione prolungata, non stimolante - synthetika